Literature DB >> 27471627

miRNA dynamics in tumor-infiltrating myeloid cells modulating tumor progression in pancreatic cancer.

Leonie Mühlberg1, Benjamin Kühnemuth1, Eithne Costello2, Victoria Shaw2, Bence Sipos3, Magdalena Huber4, Heidi Griesmann5, Sebastian Krug5, Marvin Schober5, Thomas M Gress1, Patrick Michl6.   

Abstract

Myeloid cells including tumor-associated macrophages (TAM) and myeloid-derived suppressor cells (MDSC) are known as important mediators of tumor progression in solid tumors such as pancreatic cancer. Infiltrating myeloid cells have been identified not only in invasive tumors, but also in early pre-invasive pancreatic intraepithelial precursor lesions (PanIN). The functional dynamics of myeloid cells during carcinogenesis is largely unknown. We aimed to systematically elucidate phenotypic and transcriptional changes in infiltrating myeloid cells during carcinogenesis and tumor progression in a genetic mouse model of pancreatic cancer. Using murine pancreatic myeloid cells isolated from the genetic mouse model at different time points during carcinogenesis, we examined both established markers of macrophage polarization using RT-PCR and FACS as well as transcriptional changes focusing on miRNA profiling. Myeloid cells isolated during carcinogenesis showed a simultaneous increase of established markers of M1 and M2 polarization during carcinogenesis, indicating that phenotypic changes of myeloid cells during carcinogenesis do not follow the established M1/M2 classification. MiRNA profiling revealed distinct regulations of several miRNAs already present in myeloid cells infiltrating pre-invasive PanIN lesions. Among them miRNA-21 was significantly increased in myeloid cells surrounding both PanIN lesions and invasive cancers. Functionally, miRNA-21-5p and -3p altered expression of the immune-modulating cytokines CXCL-10 and CCL-3 respectively. Our data indicate that miRNAs are dynamically regulated in infiltrating myeloid cells during carcinogenesis and mediate their functional phenotype by facilitating an immune-suppressive tumor-promoting micro-milieu.

Entities:  

Keywords:  Macrophage; PDCD4; miRNA-21; pancreatic cancer; polarization

Year:  2016        PMID: 27471627      PMCID: PMC4938301          DOI: 10.1080/2162402X.2016.1160181

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  43 in total

Review 1.  microRNAs in the tumor microenvironment: solving the riddle for a better diagnostics.

Authors:  Kishore B Challagundla; Francesca Fanini; Ivan Vannini; Petra Wise; Mariam Murtadha; Lawrence Malinconico; Amelia Cimmino; Muller Fabbri
Journal:  Expert Rev Mol Diagn       Date:  2014-06       Impact factor: 5.225

2.  High macrophage infiltration along the tumor front correlates with improved survival in colon cancer.

Authors:  Johan Forssell; Ake Oberg; Maria L Henriksson; Roger Stenling; Andreas Jung; Richard Palmqvist
Journal:  Clin Cancer Res       Date:  2007-03-01       Impact factor: 12.531

Review 3.  Pancreatic cancer microenvironment.

Authors:  Jörg Kleeff; Philipp Beckhove; Irene Esposito; Stephan Herzig; Peter E Huber; J Matthias Löhr; Helmut Friess
Journal:  Int J Cancer       Date:  2007-08-15       Impact factor: 7.396

4.  Dynamics of the immune reaction to pancreatic cancer from inception to invasion.

Authors:  Carolyn E Clark; Sunil R Hingorani; Rosemarie Mick; Chelsea Combs; David A Tuveson; Robert H Vonderheide
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

5.  Tumour-educated macrophages display a mixed polarisation and enhance pancreatic cancer cell invasion.

Authors:  Emelie Karnevi; Roland Andersson; Ann H Rosendahl
Journal:  Immunol Cell Biol       Date:  2014-03-25       Impact factor: 5.126

6.  Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse.

Authors:  Silke Reinartz; Tim Schumann; Florian Finkernagel; Annika Wortmann; Julia M Jansen; Wolfgang Meissner; Michael Krause; Anne-Marie Schwörer; Uwe Wagner; Sabine Müller-Brüsselbach; Rolf Müller
Journal:  Int J Cancer       Date:  2013-07-19       Impact factor: 7.396

Review 7.  Turning 21: Induction of miR-21 as a Key Switch in the Inflammatory Response.

Authors:  Frederick J Sheedy
Journal:  Front Immunol       Date:  2015-01-29       Impact factor: 7.561

8.  A genome-wide investigation of microRNA expression identifies biologically-meaningful microRNAs that distinguish between high-risk and low-risk intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Jennifer Permuth-Wey; Y Ann Chen; Kate Fisher; Susan McCarthy; Xiaotao Qu; Mark C Lloyd; Agnieszka Kasprzak; Michelle Fournier; Vonetta L Williams; Kavita M Ghia; Sean J Yoder; Laura Hall; Christina Georgeades; Funmilayo Olaoye; Kazim Husain; Gregory M Springett; Dung-Tsa Chen; Timothy Yeatman; Barbara Ann Centeno; Jason Klapman; Domenico Coppola; Mokenge Malafa
Journal:  PLoS One       Date:  2015-01-21       Impact factor: 3.240

9.  MicroRNA-17, 20a regulates the proangiogenic function of tumor-associated macrophages via targeting hypoxia-inducible factor 2α.

Authors:  Zhenqun Xu; Lan Zhao; Ling-Yan Zhu; Min He; Limin Zheng; Yan Wu
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

10.  MicroRNA-107 promotes proliferation of gastric cancer cells by targeting cyclin dependent kinase 8.

Authors:  Yan-qiang Song; Xu-hui Ma; Gui-liang Ma; Bin Lin; Chao Liu; Quan-jiang Deng; Wen-ping Lv
Journal:  Diagn Pathol       Date:  2014-08-28       Impact factor: 2.644

View more
  7 in total

Review 1.  Myeloid-derived suppressor cells and their role in pancreatic cancer.

Authors:  M Pergamo; G Miller
Journal:  Cancer Gene Ther       Date:  2016-12-02       Impact factor: 5.987

2.  INSC Is Down-Regulated in Colon Cancer and Correlated to Immune Infiltration.

Authors:  Tao Yu; Dan Li; Zhi Zeng; Xu Xu; Haiming Zhang; Jie Wu; Wei Song; Hua Zhu
Journal:  Front Genet       Date:  2022-05-19       Impact factor: 4.772

3.  Patterns of immune infiltration in lung adenocarcinoma revealed a prognosis-associated microRNA-mast cells network.

Authors:  Chunlin Wang; Xi Tang; Jiaojian Wang; Yanhua Xu
Journal:  Hum Cell       Date:  2019-12-20       Impact factor: 4.174

Review 4.  MicroRNAs: The Link between the Metabolic Syndrome and Oncogenesis.

Authors:  Adriana Fodor; Andrada Luciana Lazar; Cristina Buchman; Brandusa Tiperciuc; Olga Hilda Orasan; Angela Cozma
Journal:  Int J Mol Sci       Date:  2021-06-13       Impact factor: 5.923

Review 5.  Macrophage MicroRNAs as Therapeutic Targets for Atherosclerosis, Metabolic Syndrome, and Cancer.

Authors:  Yuanyuan Wei; Mengyu Zhu; Andreas Schober
Journal:  Int J Mol Sci       Date:  2018-06-13       Impact factor: 5.923

6.  MicroRNA-153 suppresses human laryngeal squamous cell carcinoma migration and invasion by targeting the SNAI1 gene.

Authors:  Binbin Zhang; Tao Fu; Lun Zhang
Journal:  Oncol Lett       Date:  2018-08-13       Impact factor: 2.967

7.  Cathepsin Inhibition Modulates Metabolism and Polarization of Tumor-Associated Macrophages.

Authors:  Diana Oelschlaegel; Tommy Weiss Sadan; Seth Salpeter; Sebastian Krug; Galia Blum; Werner Schmitz; Almut Schulze; Patrick Michl
Journal:  Cancers (Basel)       Date:  2020-09-10       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.